2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Lung Neoplasms
3
Neoplasms
2
Motor Activity
2
Breast Neoplasms
2
Anxiety Disorders
2
Stress Disorders, Post-Traumatic
1
Social Stigma
1
Noonan Syndrome
1
Neurofibromatosis 1
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Acute
1
Legius syndrome
1
Hematologic Neoplasms
1
Genetic Diseases, Inborn
1
Generalized Anxiety Disorder
1
Fatigue
1
Depression
1
Costello Syndrome
1
Chronic Pain
1
Cardiofaciocutaneous syndrome
1
Breast Cancer With Chronic Lymphedema
1
Breast Cancer Female
1
Interventions
Tamoxifen
4
Exercise
3
pyrotinib
2
abemaciclib
2
Paclitaxel
2
Metformin
2
Letrozole
2
Cyclophosphamide
2
Control Groups
2
Capecitabine
2
Bupivacaine
2
Aromatase Inhibitors
2
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
palbociclib
1
iniparib
1
exemestane
1
durvalumab
1
darolutamide
1
Yoga
1
Waiting Lists
1
Vitamin D
1
Tumor Burden
1
Tretinoin
1
Trastuzumab
1
Tocopherols
1
Thioctic Acid
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Cancer Female
×
Waiting Lists
×
Clear all
NCT03339518
2019-10-10
BRIM3
West Virginia University
Phase NA
Completed
173 enrolled